Literature DB >> 10482592

Replication of GB virus C (hepatitis G virus) in interferon-resistant Daudi cells.

Y K Shimizu1, M Hijikata, T Kiyohara, Y Kitamura, H Yoshikura.   

Abstract

We previously reported that Daudi cells, a Burkitt's lymphoma cell line, were capable of supporting productive infection of hepatitis C virus (HCV). During continual cultivation after HCV infection, the culture became resistant to interferons (IFNs). This resistant cell line, coded as H-903, was used as host cells for replication of GB virus C (GBV-C), also known as hepatitis G virus. GBV-C RNA was detected in the culture by reverse transcription-PCR for more than 130 days after inoculation, while it was detected for 44 days but not later in the parental IFN-sensitive Daudi cells. Productive infection of GBV-C in the H-903 system was confirmed by serially inoculating supernatants from infected cultures into uninfected cells. The viral E2 antigen was detected by immunofluorescence in the cells inoculated with the fifth passage of GBV-C. The presumed capsid-coding region of the viral genome in the inoculum, in the serially passaged virus, or in the virus produced by a long-term culture was only 16 amino acids long, suggesting that the GBV-C with a short core sequence was replication competent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482592      PMCID: PMC112859          DOI: 10.1128/JVI.73.10.8411-8414.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization.

Authors:  J N Simons; S M Desai; D E Schultz; S M Lemon; I K Mushahwar
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.

Authors:  H J Alter; Y Nakatsuji; J Melpolder; J Wages; R Wesley; J W Shih; J P Kim
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

3.  In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus.

Authors:  M Fogeda; S Navas; J Martín; M Casqueiro; E Rodríguez; C Arocena; V Carreño
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus.

Authors:  Y K Shimizu; M Oomura; K Abe; M Uno; E Yamada; Y Ono; T Shikata
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.

Authors:  Y K Shimizu; H Igarashi; T Kiyohara; T Cabezon; P Farci; R H Purcell; H Yoshikura
Journal:  Virology       Date:  1996-09-15       Impact factor: 3.616

6.  Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro.

Authors:  Y K Shimizu; R H Purcell; H Yoshikura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.

Authors:  M Hijikata; Y K Shimizu; H Kato; A Iwamoto; J W Shih; H J Alter; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Hepatitis C virus: detection of intracellular virus particles by electron microscopy.

Authors:  Y K Shimizu; S M Feinstone; M Kohara; R H Purcell; H Yoshikura
Journal:  Hepatology       Date:  1996-02       Impact factor: 17.425

9.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

10.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

View more
  4 in total

Review 1.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

2.  Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells.

Authors:  J Xiang; S Wünschmann; W Schmidt; J Shao; J T Stapleton
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro.

Authors:  Ernest T Chivero; Nirjal Bhattarai; Robert T Rydze; Mark A Winters; Mark Holodniy; Jack T Stapleton
Journal:  J Gen Virol       Date:  2014-03-25       Impact factor: 3.891

4.  Recombination among GB virus C (GBV-C) isolates in the United States.

Authors:  Jason T Blackard; Gang Ma; Clarissa Polen; Juwen C DuBois; Jonathon Gast; Caleb M Radens; Richard K Sterling; Kenneth E Sherman
Journal:  J Gen Virol       Date:  2016-04-11       Impact factor: 3.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.